Literature DB >> 20738013

The possible role of cytokines in chemotherapy-induced cognitive deficits.

Jamie S Myers1.   

Abstract

roinflammatory cytokines play a significant role in the body's immune response to pathogens, including malignant cells. Proinflammatory cytokines are associated with tumor invasion and progressive disease and are released in response to many antineoplastic agents. Exogenous administration and endogenous production ofcytokines is related to a pattern of behaviors known as sickness behavior that has a significant impact on patients' quality of life. The behavioral patterns associated with sickness behavior include inability to concentrate and impaired learning. Identification of sequelae specific to individual cytokine activity provides novel targets for investigation.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20738013     DOI： 10.1007/978-1-4419-6306-2_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


  9 in total

Review 1.  Cancer-treatment-induced neurotoxicity--focus on newer treatments.

Authors:  Jacqueline B Stone; Lisa M DeAngelis
Journal:  Nat Rev Clin Oncol       Date:  2015-09-22       Impact factor: 66.675

2.  The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer.

Authors:  K L Pomykala; P A Ganz; J E Bower; L Kwan; S A Castellon; S Mallam; I Cheng; R Ahn; E C Breen; M R Irwin; D H S Silverman
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

3.  Changes in cognition and dendritic complexity following intrathecal methotrexate and cytarabine treatment in a juvenile murine model.

Authors:  Tyler C Alexander; Christy M Simecka; Frederico Kiffer; Thomas Groves; Julie Anderson; Hannah Carr; Jing Wang; Gwendolyn Carter; Antiño R Allen
Journal:  Behav Brain Res       Date:  2017-12-08       Impact factor: 3.332

4.  Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research.

Authors:  Andrew J Saykin; Michiel B de Ruiter; Brenna C McDonald; Sabine Deprez; Daniel H S Silverman
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

5.  Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.

Authors:  Yin Ting Cheung; Michelle N Edelmann; Daniel A Mulrooney; Daniel M Green; Wassim Chemaitilly; Neena John; Leslie L Robison; Melissa M Hudson; Kevin R Krull
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-06-26       Impact factor: 4.254

6.  Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study.

Authors:  Y T Cheung; T Ng; M Shwe; H K Ho; K M Foo; M T Cham; J A Lee; G Fan; Y P Tan; W S Yong; P Madhukumar; S K Loo; S F Ang; M Wong; W Y Chay; W S Ooi; R A Dent; Y S Yap; R Ng; A Chan
Journal:  Ann Oncol       Date:  2015-04-28       Impact factor: 32.976

Review 7.  Cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future research.

Authors:  Yin Ting Cheung; Si Rong Lim; Han Kiat Ho; Alexandre Chan
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

8.  Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients.

Authors:  Jung-Woo Chae; Terence Ng; Hui Ling Yeo; Maung Shwe; Yan Xiang Gan; Han Kiat Ho; Alexandre Chan
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240

9.  Fluvoxamine alleviates paclitaxel-induced neurotoxicity.

Authors:  Hitoshi Tanimukai; Takashi Kudo
Journal:  Biochem Biophys Rep       Date:  2015-09-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.